Does inhibition of glycogen synthase kinase protect in mice?
about
The GSK-3 family as therapeutic target for myocardial diseasesMitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.Selective blockade of protein kinase B protects the rat and human myocardium against ischaemic injuryGSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in miceCardioprotection leads to novel changes in the mitochondrial proteome.Characterization and functional expression of the natriuretic peptide system in human lens epithelial cellsGlycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivoTargeting GSK-3 family members in the heart: a very sharp double-edged sword.Inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury by way of an interleukin-10-mediated immune regulatory mechanism.Catestatin exerts direct protective effects on rat cardiomyocytes undergoing ischemia/reperfusion by stimulating PI3K-Akt-GSK3β pathway and preserving mitochondrial membrane potentialCardioprotection and altered mitochondrial adenine nucleotide transportAldose reductase modulates cardiac glycogen synthase kinase-3β phosphorylation during ischemia-reperfusion.Role of glycogen synthase kinase-3beta in cardioprotection.The potential role of sphingolipid-mediated cell signaling in the interaction between hyperglycemia, acute myocardial infarction and heart failure.Insufficient activation of Akt upon reperfusion because of its novel modification by reduced PP2A-B55α contributes to enlargement of infarct size by chronic kidney disease.Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs.
P2860
Q26861134-04A54725-D2C7-4F38-AEE7-007DD4132419Q28296128-8603BF83-EE7D-40DB-84D3-82D1C5842732Q28567327-C424C78D-1A81-4FD1-A986-D5AED85FBFF0Q28590516-E2DB7512-4E63-488C-9E92-FE7FED227D20Q33589244-075C412E-AB6F-497A-921D-B429926DC956Q33781337-11814E30-A1F8-42DE-B4EC-AD22370F6826Q33954489-D54E4D1F-8238-470B-A178-868422038799Q34785999-18800DD9-F530-46BD-94AE-883D0B49EEB0Q35131974-02DD8270-F88F-45B5-BA1D-D70489F5C309Q35182058-55728805-D2AA-4D0C-ACEA-C941BCC8B2D4Q36101537-8A51D7B0-EB90-4B8F-8774-60935DB0992DQ36176141-DD4D673C-D7A8-4825-8981-51895120EE37Q37303154-D68FFC99-30F5-47C6-8243-A315639E44A7Q38023943-FB8ADDD7-87E7-434C-914D-882DE37BB084Q38706998-A49C5B2A-3C46-4E7B-8652-6F9EF17D248CQ43298149-81262E7A-F2E0-421D-955D-75EE7D168504
P2860
Does inhibition of glycogen synthase kinase protect in mice?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Does inhibition of glycogen synthase kinase protect in mice?
@en
Does inhibition of glycogen synthase kinase protect in mice?
@nl
type
label
Does inhibition of glycogen synthase kinase protect in mice?
@en
Does inhibition of glycogen synthase kinase protect in mice?
@nl
prefLabel
Does inhibition of glycogen synthase kinase protect in mice?
@en
Does inhibition of glycogen synthase kinase protect in mice?
@nl
P2860
P1433
P1476
Does inhibition of glycogen synthase kinase protect in mice?
@en
P2093
Charles Steenbergen
Elizabeth Murphy
P2860
P304
P356
10.1161/CIRCRESAHA.108.181602
P577
2008-08-01T00:00:00Z